- Home
- ASTI vs LIPO Comparison
ASTI vs LIPO Comparison
Compare ASTI & LIPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTI
- LIPO
- Stock Information
- Founded
- ASTI 2005
- LIPO 2005
- Country
- ASTI United States
- LIPO United States
- Employees
- ASTI N/A
- LIPO N/A
- Industry
- ASTI Semiconductors
- LIPO Biotechnology: Pharmaceutical Preparations
- Sector
- ASTI Technology
- LIPO Health Care
- Exchange
- ASTI Nasdaq
- LIPO Nasdaq
- Market Cap
- ASTI 3.1M
- LIPO 3.1M
- IPO Year
- ASTI N/A
- LIPO 2022
- Fundamental
- Price
- ASTI $1.34
- LIPO $2.58
- Analyst Decision
- ASTI
- LIPO Strong Buy
- Analyst Count
- ASTI 0
- LIPO 1
- Target Price
- ASTI N/A
- LIPO $16.00
- AVG Volume (30 Days)
- ASTI 129.5K
- LIPO 45.6K
- Earning Date
- ASTI 05-08-2025
- LIPO 05-08-2025
- Dividend Yield
- ASTI N/A
- LIPO N/A
- EPS Growth
- ASTI N/A
- LIPO N/A
- EPS
- ASTI N/A
- LIPO N/A
- Revenue
- ASTI $41,893.00
- LIPO $536,357.00
- Revenue This Year
- ASTI N/A
- LIPO N/A
- Revenue Next Year
- ASTI N/A
- LIPO N/A
- P/E Ratio
- ASTI N/A
- LIPO N/A
- Revenue Growth
- ASTI N/A
- LIPO 19.29
- 52 Week Low
- ASTI $1.20
- LIPO $2.02
- 52 Week High
- ASTI $37.50
- LIPO $12.00
- Technical
- Relative Strength Index (RSI)
- ASTI 30.69
- LIPO 48.75
- Support Level
- ASTI $1.25
- LIPO $2.13
- Resistance Level
- ASTI $1.90
- LIPO $2.71
- Average True Range (ATR)
- ASTI 0.14
- LIPO 0.21
- MACD
- ASTI -0.03
- LIPO 0.05
- Stochastic Oscillator
- ASTI 18.67
- LIPO 77.46
About ASTI Ascent Solar Technologies Inc.
Ascent Solar Technologies Inc is engaged in the manufacturing and selling of photovoltaic products (PV) solar modules that are flexible, durable, and possess attractive power-to-weight and power-to-area performance. The company is integrating its PV products into scalable and high-value markets such as agrivoltaics, aerospace, satellites, near-earth orbiting vehicles, and fixed-wing unmanned aerial vehicles (UAV). Ascent is also working to expand its portable solar chargers, such as the XD-12. The company markets and sells its products through OEMs, system integrators, distributors, retailers, and e-commerce companies.
About LIPO Lipella Pharmaceuticals Inc.
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.